[PHARMA] YoY Annualized Quarter Result on 31-Mar-2024 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
27-May-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
31-Mar-2024 [#1]
Profit Trend
QoQ- 232.45%
YoY- 868.5%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 3,859,836 3,521,816 3,848,696 3,173,996 3,279,684 3,144,432 2,471,692 7.70%
PBT 156,176 36,772 149,756 126,096 123,520 120,972 114,828 5.25%
Tax -51,460 -25,708 -34,332 -34,784 -33,860 -42,380 -44,472 2.45%
NP 104,716 11,064 115,424 91,312 89,660 78,592 70,356 6.84%
-
NP to SH 102,584 10,592 110,936 92,544 89,596 78,468 70,344 6.48%
-
Tax Rate 32.95% 69.91% 22.93% 27.59% 27.41% 35.03% 38.73% -
Total Cost 3,755,120 3,510,752 3,733,272 3,082,684 3,190,024 3,065,840 2,401,336 7.72%
-
Net Worth -272,392 -142,812 413,947 355,919 350,047 528,825 524,838 -
Dividend
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Div - - 41,918 41,872 62,695 62,521 51,964 -
Div Payout % - - 37.79% 45.25% 69.98% 79.68% 73.87% -
Equity
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Net Worth -272,392 -142,812 413,947 355,919 350,047 528,825 524,838 -
NOSH 1,441,229 1,310,208 1,309,126 261,705 261,229 260,505 259,821 33.01%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 2.71% 0.31% 3.00% 2.88% 2.73% 2.50% 2.85% -
ROE 0.00% 0.00% 26.80% 26.00% 25.60% 14.84% 13.40% -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
RPS 267.82 268.80 293.80 1,212.81 1,255.48 1,207.05 951.31 -19.02%
EPS 7.12 0.80 8.48 35.36 34.28 30.12 27.08 -19.94%
DPS 0.00 0.00 3.20 16.00 24.00 24.00 20.00 -
NAPS -0.189 -0.109 0.316 1.36 1.34 2.03 2.02 -
Adjusted Per Share Value based on latest NOSH - 1,441,229
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
RPS 267.81 244.36 267.04 220.22 227.56 218.17 171.50 7.70%
EPS 7.12 0.73 7.70 6.42 6.22 5.44 4.88 6.49%
DPS 0.00 0.00 2.91 2.91 4.35 4.34 3.61 -
NAPS -0.189 -0.0991 0.2872 0.247 0.2429 0.3669 0.3642 -
Price Multiplier on Financial Quarter End Date
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Date 29/03/24 31/03/23 31/03/22 31/03/21 31/03/20 29/03/19 30/03/18 -
Price 0.355 0.285 0.755 3.26 1.26 2.27 4.28 -
P/RPS 0.13 0.11 0.26 0.27 0.10 0.19 0.45 -18.67%
P/EPS 4.99 35.25 8.92 9.22 3.67 7.54 15.81 -17.47%
EY 20.05 2.84 11.22 10.85 27.22 13.27 6.33 21.16%
DY 0.00 0.00 4.24 4.91 19.05 10.57 4.67 -
P/NAPS 0.00 0.00 2.39 2.40 0.94 1.12 2.12 -
Price Multiplier on Announcement Date
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Date 27/05/24 18/05/23 20/05/22 21/05/21 19/05/20 16/05/19 16/05/18 -
Price 0.39 0.38 0.72 4.03 1.88 2.36 4.07 -
P/RPS 0.15 0.14 0.25 0.33 0.15 0.20 0.43 -16.08%
P/EPS 5.48 47.01 8.50 11.40 5.48 7.83 15.03 -15.46%
EY 18.25 2.13 11.76 8.77 18.24 12.76 6.65 18.30%
DY 0.00 0.00 4.44 3.97 12.77 10.17 4.91 -
P/NAPS 0.00 0.00 2.28 2.96 1.40 1.16 2.01 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment